Wednesday, December 8, 2021

SPARC inks licensing pact with Visiox Pharma for ophthalmic products

SPARC inks licensing pact with Visiox Pharma for ophthalmic products The company has entered into an agreement with Visiox Pharma LLC (Visiox) to grant exclusive worldwide rights (except for India and Greater China) for the development and commercialisation of PDP-716 and SDN-037, SPARC said in a statement.

from Moneycontrol Business News https://ift.tt/3IumBz4
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Largecap valuations near fair value, time to start deploying: Jyotivardhan Jaipuria

​So, banks are cheap. And second is, at these valuations, a lot of bad news is priced in. So, as we see growth coming back, as we see things...